Pasar al contenido principal

ESTUDIO DE LOS MECANISMOS MOLECULARES IMPLICADOS EN EL MALPLEGAMIENTO ESPONTANEO DE LA PROTEINA DEL PRION

RTI2018-098515-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario ASOCIACION CENTRO DE INVESTIGACION COOP EN BIOCIENCIAS CIC BIOGUNE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Homozygous R136S mutation in PRNP gene causes inherited early onset prion disease

  • Ximelis, Teresa
  • Marín-Moreno, Alba
  • Espinosa, Juan Carlos
  • Eraña, Hasier
  • Charco, Jorge M.
  • Hernández, Isabel
  • Riveira, Carmen
  • Alcolea, Daniel
  • González-Roca, Eva
  • Aldecoa, Iban
  • Molina-Porcel, Laura
  • Parchi, Piero
  • Rossi, Marcello
  • Castilla, Joaquín
  • Ruiz-García, Raquel
  • Gelpi, Ellen
  • Torres, Juan María
  • Sánchez-Valle, Raquel
13 Pág. Centro de Investigación en Sanidad Animal (CISA), More than 40 pathogenic heterozygous PRNP mutations causing inherited prion diseases have been identified to date. Recessive inherited prion disease has not been described to date., This work was funded by the Instituto de Salud Carlos III (grant no. PI20/00448 to RSV), Spanish Ministerio de Ciencia e Innovación (grant no. PDI2019-105837RB-I00 to J.M.T. and J.C.E., and RTI2018-098515-B-I00 to J.C.), Fundació La Marató de TV3 (grant no. 201821-31 to J.C.E.), Instituto Nacional de Investigación y Tecnología Agraria y Agroalimentaria (fellowship INIA-FPI-SGIT-2015-02 to A.M.M.) and Dr Baselga funds for CJD research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Glycans are not necessary to maintain the pathobiological features of bovine spongiform encephalopathy

  • Otero, Alicia
  • Barrio, Tomás
  • Eraña, Hasier
  • Charco, Jorge M.
  • Betancor, Marina
  • Díaz-Domínguez, Carlos M.
  • Marín, Belén
  • Andréoletti, Olivier
  • Torres, Juan María
  • Kong, Qingzhong
  • Badiola, Juan J.
  • Bolea, Rosa
  • Castilla, Joaquín
22 Päg., The role of the glycosylation status of PrPC in the conversion to its pathological counterpart and on cross-species transmission of prion strains has been widely discussed. Here, we assessed the effect on strain characteristics of bovine spongiform encephalopathy (BSE) isolates with different transmission histories upon propagation on a model expressing a non-glycosylated human PrPC. Bovine, ovine and porcine-passaged BSE, and variant Creutzfeldt-Jakob disease (vCJD) isolates were used as seeds/inocula in both in vitro and in vivo propagation assays using the non-glycosylated human PrPC-expressing mouse model (TgNN6h). After protein misfolding cyclic amplification (PMCA), all isolates maintained the biochemical characteristics of BSE. On bioassay, all PMCA-propagated BSE prions were readily transmitted to TgNN6h mice, in agreement with our previous in vitro results. TgNN6h mice reproduced the characteristic neuropathological and biochemical hallmarks of BSE, suggesting that the absence of glycans did not alter the pathobiological features of BSE prions. Moreover, back-passage of TgNN6h-adapted BSE prions to BoTg110 mice recovered the full BSE phenotype, confirming that the glycosylation of human PrPC is not essential for the preservation of the human transmission barrier for BSE prions or for the maintenance of BSE strain properties., This work was supported financially by the following Spanish and European Interreg grants: RB, AGL2015-65560-R, MINECO Ministerio de Economía y Competitividad (Spanish Government) https://sede.mineco.gob.es/; RB, RTI2018-098711-B-I00, Ministerio de Ciencia, Innovación y Universidades (Spanish Government) https://www.ciencia.gob.es/; JC, RTI2018-098515-B-I00, Ministerio de Ciencia, Innovación y Universidades (Spanish Government) https://www.ciencia.gob.es/; JC, PID2021-122201OB-C21, Ministerio de Ciencia, Innovación y Universidades (Spanish Government) https://www.ciencia.gob.es/ partially supported by European Region Development Fund(ERDF) https://ec.europa.eu/regional_policy/en/funding/erdf/ ;RB & JJB, POCTEFA EFA148/16, European Region Development Fund (ERDF) https://ec.europa.eu/regional_policy/en/funding/erdf/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Homozygous R136S mutation in PRNP gene causes inherited early onset prion disease

  • Ximelis, Teresa
  • Marín-Moreno, Alba|||0000-0002-4023-6398
  • Espinosa, Juan Carlos
  • Eraña, Hasier|||0000-0001-8776-4211
  • Charco, Jorge M.|||0000-0003-3476-1855
  • Hernández, Isabel|||0000-0001-8119-393X
  • Riveira, Carmen
  • Alcolea, Daniel|||0000-0002-3819-3245
  • González Roca, Eva|||0000-0002-1126-0321
  • Aldecoa, Iban|||0000-0001-5774-7453
  • Molina-Porcel, Laura|||0000-0003-4068-8578
  • Parchi, Piero
  • Rossi, Marcello
  • Castilla, Joaquín|||0000-0002-2216-1361
  • Ruiz-García, Raquel
  • Gelpi, Ellen|||0000-0003-2948-4187
  • Torres, Juan María
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
Background: More than 40 pathogenic heterozygous PRNP mutations causing inherited prion diseases have been identified to date. Recessive inherited prion disease has not been described to date. Methods: We describe the clinical and neuropathological data of inherited early-onset prion disease caused by the rare PRNP homozygous mutation R136S. In vitro PrP propagation studies were performed using recombinant-adapted protein misfolding cyclic amplification technique. Brain material from two R136S homozygous patients was intracranially inoculated in TgMet129 and TgVal129 transgenic mice to assess the transmissibility of this rare inherited form of prion disease. Results: The index case presented symptoms of early-onset dementia beginning at the age of 49 and died at the age of 53. Neuropathological evaluation of the proband revealed abundant multicentric PrP plaques and Western blotting revealed a ~ 8 kDa protease-resistant, unglycosylated PrP fragment, consistent with a Gerstmann-Sträussler-Scheinker phenotype. Her youngest sibling suffered from progressive cognitive decline, motor impairment, and myoclonus with onset in her late 30s and died at the age of 48. Genetic analysis revealed the presence of the R136S mutation in homozygosis in the two affected subjects linked to homozygous methionine at codon 129. One sibling carrying the heterozygous R136S mutation, linked to homozygous methionine at codon 129, is still asymptomatic at the age of 74. The inoculation of human brain homogenates from our index case and an independent case from a Portuguese family with the same mutation in transgenic mice expressing human PrP and in vitro propagation of PrP studies failed to show disease transmissibility. Conclusion: In conclusion, biallelic R136S substitution is a rare variant that produces inherited early-onset human prion disease with a Gerstmann-Sträussler-Scheinker neuropathological and molecular signature. Even if the R136S variant is predicted to be "probably damaging", heterozygous carriers are protected, at least from an early onset providing evidence for a potentially recessive pattern of inheritance in human prion diseases.